drugset / Trial / NCT01383356

Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet

NCT01383356

Phase 1 Completed 58 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelBasic science

Summary

The data from this study will be used to compare the kinetic profile of metformin 500mg in linagliptin/metformin fixed dose combination tablet versus Canadian metformin reference product administered concomitantly with linagliptin 2.5 mg tablet.

Timeline

Start
2011-06
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Linagliptin Small molecule 2.5 mg
Subject Metformin Small molecule 500 mg